Trade Zynerba Pharmaceuticals, Inc. - ZYNE CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02354% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001318% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.25 |
| Open | 1.25 |
| 1-Year Change | 73.61% |
| Day's Range | 1.25 - 1.31 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Oct 10, 2023 | 1.29 | 0.05 | 4.03% | 1.24 | 1.31 | 1.24 |
| Oct 9, 2023 | 1.25 | 0.04 | 3.31% | 1.21 | 1.26 | 1.21 |
| Oct 6, 2023 | 1.25 | 0.05 | 4.17% | 1.20 | 1.25 | 1.20 |
| Oct 5, 2023 | 1.24 | 0.06 | 5.08% | 1.18 | 1.24 | 1.18 |
| Oct 4, 2023 | 1.19 | -0.04 | -3.25% | 1.23 | 1.24 | 1.16 |
| Oct 3, 2023 | 1.24 | 0.00 | 0.00% | 1.24 | 1.24 | 1.21 |
| Oct 2, 2023 | 1.24 | -0.01 | -0.80% | 1.25 | 1.25 | 1.23 |
| Sep 29, 2023 | 1.25 | -0.01 | -0.79% | 1.26 | 1.26 | 1.24 |
| Sep 28, 2023 | 1.26 | 0.01 | 0.80% | 1.25 | 1.26 | 1.25 |
| Sep 27, 2023 | 1.25 | 0.01 | 0.81% | 1.24 | 1.28 | 1.24 |
| Sep 26, 2023 | 1.26 | -0.04 | -3.08% | 1.30 | 1.31 | 1.25 |
| Sep 25, 2023 | 1.30 | 0.00 | 0.00% | 1.30 | 1.30 | 1.30 |
| Sep 22, 2023 | 1.31 | 0.01 | 0.77% | 1.30 | 1.32 | 1.30 |
| Sep 21, 2023 | 1.30 | -0.01 | -0.76% | 1.31 | 1.33 | 1.29 |
| Sep 20, 2023 | 1.33 | 0.03 | 2.31% | 1.30 | 1.34 | 1.30 |
| Sep 19, 2023 | 1.31 | 0.00 | 0.00% | 1.31 | 1.33 | 1.31 |
| Sep 18, 2023 | 1.31 | -0.02 | -1.50% | 1.33 | 1.34 | 1.31 |
| Sep 15, 2023 | 1.36 | 0.05 | 3.82% | 1.31 | 1.37 | 1.31 |
| Sep 14, 2023 | 1.32 | 0.02 | 1.54% | 1.30 | 1.32 | 1.30 |
| Sep 13, 2023 | 1.30 | 0.00 | 0.00% | 1.30 | 1.33 | 1.30 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Zynerba Pharmaceuticals, Inc.
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It improves the lives of patients and their families living with severe, chronic health conditions, including Fragile X syndrome, autism spectrum disorder, 22q11.2 deletion syndrome, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania.| Industry: | Biotechnology & Medical Research (NEC) |
80 W. Lancaster Avenue
Suite 300
DEVON
PENNSYLVANIA 19333
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com